-
Oct 9, 2024 | 
mondaq.com | David Burns
This article explores some key factors a bridging lender may
consider when deciding whether to enforce its security, as well as
the main methods of enforcement available to lenders.
1. Has the borrower defaulted?
If so, is the breach serious enough to justify enforcement, or
are there alternative solutions that should be explored first?
2. What is the borrower's financial
position?
Can the borrower realistically repay the loan within a
reasonable period?
-
Sep 23, 2024 | 
mondaq.com | David Burns
A Property Joint Venture is a business arrangement where two or
more parties agree to collaborate for the purpose of creating
value, typically through the acquisition, development, and/or
management of a property.
Joint ventures are a popular method of sharing risk and pooling
knowledge and expertise, enabling investors to access properties
that might otherwise be unattainable or unsuitable for a single
party.
-
Sep 20, 2024 | 
mondaq.com | David Burns
RF
Ronald Fletcher Baker
More
For over 75 years, Ronald Fletcher Baker LLP has been providing expert legal advice from its offices in London, Manchester, and Exeter. The firm has considerable experience in acting for medium to large national and international companies, governments, financial institutions, high net worth individuals, families, and corporate investors, many of whom are based overseas.
-
Sep 20, 2024 | 
mondaq.com | David Burns
Note: This article examines the remedies available to
landlords when a commercial tenant breaches a lease. It does not
cover remedies for non-payment of rent, as this is detailed in the
article "What to Do If Your Commercial Tenant Is Not
Paying Rent".
-
Sep 20, 2024 | 
mondaq.com | David Burns
Bridging finance is often used by property developers and
investors in various situations, for example, where investors are
buying a new property while waiting for the sale of another
property or waiting for a refinance on another property. Before
obtaining bridging finance it is worthwhile considering your exit
strategies and understanding the consequences in the event that you
default on the loan.
Failing to repay a bridging loan on time can have serious
consequences.
-
Jul 18, 2024 | 
lexology.com | David Burns
What are Property Joint Ventures? A Property Joint Venture is a business arrangement where two or more parties agree to collaborate for the purpose of creating value, typically through the acquisition, development, and/or management of a property. Joint ventures are a popular method of sharing risk and pooling knowledge and expertise, enabling investors to access properties that might otherwise be unattainable or unsuitable for a single party. How are Property Joint Ventures Usually Structured?
-
Apr 16, 2024 | 
allouryesterdays.info | David Burns
Forty three years ago, on this day, April 17th, 1981, the alert was sounded. Again. WASHINGTON – The atmosphere’s carbon-dioxide content has increased 7 percent since 1958, when systematic measurement began. Scientists fear that the continued use of fossil fuel and continued land-clearing and destruction of forests will raise the quantity of CO2 to double the pre-industrial level.
-
Nov 23, 2023 | 
mondaq.com | Howard Newcomb Morse |David Burns |Megan Browdie |Jonathan Davies
The US Federal Trade Commission (FTC) sent letters on November
7, 2023, accusing 10 companies of improperly listing drug delivery
device patents in the US Food and Drug Administration (FDA) Orange
Book, stating that the FTC has taken steps to "dispute"
these listings.
-
Nov 6, 2023 | 
concurrences.com | Howard Newcomb Morse |David Burns |Megan Browdie |Jonathan Davies
The US Federal Trade Commission (FTC) sent letters on November 7, 2023, accusing 10 companies of improperly listing drug delivery device patents in the US Food and Drug Administration (FDA) Orange Book, stating that the FTC has taken steps to “dispute” these listings. The FTC’s statements suggest the potential for future antitrust enforcement actions against these companies, as well as for further disputes regarding a “wide array of patent listings.”The FTC’s letters follow the agency’s Sept...
-
Nov 6, 2023 | 
concurrences.com | Howard Newcomb Morse |David Burns |Megan Browdie |Jonathan Davies
Previous article Next article Share on | The US Federal Trade Commission (FTC) sent letters on November 7, 2023, accusing 10 companies of improperly listing drug delivery device patents in the US Food and Drug Administration (FDA) Orange Book, stating that the FTC has taken steps to “dispute” these listings.
